321 related articles for article (PubMed ID: 30371017)
1. Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score.
Kang SH; Jeong WK; Baik SK; Cha SH; Kim MY
J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):860-870. PubMed ID: 30371017
[TBL] [Abstract][Full Text] [Related]
2. Adipopenia correlates with higher portal pressure in patients with cirrhosis.
Rodrigues SG; Brabandt B; Stirnimann G; Maurer MH; Berzigotti A
Liver Int; 2019 Sep; 39(9):1672-1681. PubMed ID: 31207018
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive aspartate aminotransferase to platelet ratio index correlates well with invasive hepatic venous pressure gradient in cirrhosis.
Kirnake V; Arora A; Sharma P; Goyal M; Chawlani R; Toshniwal J; Kumar A
Indian J Gastroenterol; 2018 Jul; 37(4):335-341. PubMed ID: 30178093
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertension.
Paternostro R; Bardach C; Hofer BS; Scheiner B; Schwabl P; Asenbaum U; Ba-Ssalamah A; Scharitzer M; Bucscis T; Simbrunner B; Bauer D; Trauner M; Mandorfer M; Reiberger T; Lampichler K
Liver Int; 2021 Apr; 41(4):799-809. PubMed ID: 33290614
[TBL] [Abstract][Full Text] [Related]
5. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
[TBL] [Abstract][Full Text] [Related]
6. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
7. Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient.
Jachs M; Hartl L; Simbrunner B; Semmler G; Balcar L; Hofer BS; Schwarz M; Bauer D; Stättermayer AF; Pinter M; Trauner M; Reiberger T; Mandorfer M
J Hepatol; 2024 May; 80(5):744-752. PubMed ID: 38218352
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of a single HVPG measurement and Doppler-ultrasound evaluation in patients with cirrhosis and portal hypertension.
Berzigotti A; Rossi V; Tiani C; Pierpaoli L; Zappoli P; Riili A; Serra C; Andreone P; Morelli MC; Golfieri R; Rossi C; Magalotti D; Zoli M
J Gastroenterol; 2011 May; 46(5):687-95. PubMed ID: 21213113
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis.
Bruha R; Jachymova M; Petrtyl J; Dvorak K; Lenicek M; Urbanek P; Svestka T; Vitek L
World J Gastroenterol; 2016 Mar; 22(12):3441-50. PubMed ID: 27022226
[TBL] [Abstract][Full Text] [Related]
10. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
Wang YW; Huo TI; Yang YY; Hou MC; Lee PC; Lin HC; Lee FY; Chi CW; Lee SD
J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
[TBL] [Abstract][Full Text] [Related]
11. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis.
Suk KT; Kim CH; Park SH; Sung HT; Choi JY; Han KH; Hong SH; Kim DY; Yoon JH; Kim YS; Baik GH; Kim JB; Kim DJ
J Clin Gastroenterol; 2012; 46(10):880-6. PubMed ID: 22810110
[TBL] [Abstract][Full Text] [Related]
12. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis.
Zipprich A; Garcia-Tsao G; Rogowski S; Fleig WE; Seufferlein T; Dollinger MM
Liver Int; 2012 Oct; 32(9):1407-14. PubMed ID: 22679906
[TBL] [Abstract][Full Text] [Related]
13. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
[TBL] [Abstract][Full Text] [Related]
14. Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension.
Afdhal N; Everson GT; Calleja JL; McCaughan GW; Bosch J; Brainard DM; McHutchison JG; De-Oertel S; An D; Charlton M; Reddy KR; Asselah T; Gane E; Curry MP; Forns X
J Viral Hepat; 2017 Oct; 24(10):823-831. PubMed ID: 28295923
[TBL] [Abstract][Full Text] [Related]
15. Plasma Nogo-A and placental growth factor levels are associated with portal hypertension in patients with liver cirrhosis.
Gelman S; Salteniene V; Pranculis A; Skieceviciene J; Zykus R; Petrauskas D; Kupcinskas L; Canbay A; Link A; Kupcinskas J
World J Gastroenterol; 2019 Jun; 25(23):2935-2946. PubMed ID: 31249451
[TBL] [Abstract][Full Text] [Related]
16. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era.
Ripoll C; Bañares R; Rincón D; Catalina MV; Lo Iacono O; Salcedo M; Clemente G; Núñez O; Matilla A; Molinero LM
Hepatology; 2005 Oct; 42(4):793-801. PubMed ID: 16175621
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated liver cirrhosis].
Lee SH; Park SH; Kim GW; Lee WJ; Hong WK; Ryu MS; Park KT; Lee MY; Lee CW; Kim JH; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ
Korean J Hepatol; 2009 Sep; 15(3):350-6. PubMed ID: 19783884
[TBL] [Abstract][Full Text] [Related]
18. [Risk factors of clinically significant portal hypertension in patients with compensated liver cirrhosis based on hepatic venous pressure gradient].
Jiang FR; Yan HD
Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):995-1000. PubMed ID: 34814395
[No Abstract] [Full Text] [Related]
19. Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis.
Rincon D; Lo Iacono O; Ripoll C; Gomez-Camarero J; Salcedo M; Catalina MV; Hernando A; Clemente G; Matilla A; Nuñez O; Bañares R
Aliment Pharmacol Ther; 2007 Apr; 25(7):841-8. PubMed ID: 17373923
[TBL] [Abstract][Full Text] [Related]
20. Identification of patients with decompensated cirrhosis at high risk for death: improving the prediction by hepatic venous pressure gradient?
Park SH; Park HY; Kang JW; Park JS; Shin KJ; Kim CH; Suk KT; Baik GH; Kim JB; Kim DJ; Lee HY
Hepatogastroenterology; 2012; 59(120):2548-51. PubMed ID: 23178621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]